Oscar Health Raises Earnings Outlook After Strong Q3 Performance
Oscar Health has once again raised its full-year operational earnings outlook, marking the company's third upward revision this year, after an impressive third-quarter performance.
The latest earnings report reveals that Oscar Health has achieved remarkable revenue growth, with the company reporting $5.1 billion in revenue for the third quarter, a substantial 70% increase compared to the previous year. This growth has been fueled by increased membership and premium rates, leading to a net income of $167 million and operating earnings of $178 million, up by $307 million. Additionally, the adjusted EBITDA soared to $207 million, marking an impressive rise of $308 million.
Strategic Moves and Financial Gains
According to CEO Mark Bertolini, 2026 has been the company's strongest year to date, as Oscar Health surpasses several key objectives set during its 2024 investor presentation. The company's strategic pricing and improved utilization rates have led to significant enhancements in its medical loss ratio (MLR), which decreased by 4.5 percentage points to 84%. This improvement highlights the proportion of premiums utilized for healthcare costs, underscoring Oscar's effective management.
Despite the positive financial outlook, Chief Financial Officer Scott Blackley emphasized a cautious approach regarding the company's risk-adjustment reserves. While updated risk-adjustment data delivered a financial benefit of $250 million for the quarter, Blackley noted that not all benefits translate directly to the bottom line due to associated claims costs.
Key Financial Metrics
| Metric | Q3 2026 Achievements |
|---|---|
| Revenue Growth | 70% year-over-year |
| Net Income | $167 million |
| Operating Earnings | $178 million, increased by $307 million |
| Adjusted EBITDA | $207 million, a $308 million rise |
Operational Improvements and Future Outlook
Oscar has effectively reduced general and administrative expenses, achieving a record low of 14%, thanks to advanced technology and tight cost management. However, Blackley anticipates a slight increase in these expenses during the fourth quarter as the company invests in open enrollment and other key initiatives for 2027 expansion.
Looking ahead, Oscar expects to end 2026 with operational earnings between $850 million and $950 million and revenue between $19 billion and $19.3 billion. The company’s membership, which reached approximately 2.7 million earlier in the year, reflects a 27% year-over-year growth. However, Oscar adjusted its projections to account for anticipated disenrollments due to a CMS eligibility review.
Strategic Expansion and Competitive Positioning
In preparation for the 2027 enrollment period, Oscar has expanded its market presence and introduced innovative products, such as RetireEase and the Hy-Vee Health with Oscar offering. These moves position the company to capture market share as competitors exit the market, ensuring stability in ACA marketplace membership with a projected 14% rate increase.
Oscar Health continues to solidify its position as a technology-driven insurer, blending insurance products with digital tools to enhance care management for individuals, families, and small businesses across the U.S.